West Pharmaceutical Services Current Ratio 2010-2024 | WST

Current and historical current ratio for West Pharmaceutical Services (WST) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. West Pharmaceutical Services current ratio for the three months ending September 30, 2024 was 3.00.
West Pharmaceutical Services Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-09-30 $1.55B $0.52B 3.00
2024-06-30 $1.48B $0.63B 2.34
2024-03-31 $1.69B $0.65B 2.61
2023-12-31 $1.94B $0.67B 2.88
2023-09-30 $1.97B $0.53B 3.70
2023-06-30 $1.87B $0.51B 3.66
2023-03-31 $1.94B $0.54B 3.62
2022-12-31 $1.92B $0.52B 3.70
2022-09-30 $1.73B $0.46B 3.80
2022-06-30 $1.77B $0.57B 3.13
2022-03-31 $1.69B $0.59B 2.89
2021-12-31 $1.74B $0.59B 2.93
2021-09-30 $1.60B $0.56B 2.86
2021-06-30 $1.48B $0.47B 3.13
2021-03-31 $1.33B $0.48B 2.75
2020-12-31 $1.37B $0.50B 2.73
2020-09-30 $1.24B $0.45B 2.77
2020-06-30 $1.11B $0.38B 2.96
2020-03-31 $0.98B $0.34B 2.84
2019-12-31 $1.06B $0.34B 3.10
2019-09-30 $1.00B $0.34B 3.00
2019-06-30 $0.94B $0.31B 3.02
2019-03-31 $0.87B $0.30B 2.88
2018-12-31 $0.89B $0.28B 3.15
2018-09-30 $0.85B $0.29B 2.94
2018-06-30 $0.77B $0.29B 2.67
2018-03-31 $0.74B $0.26B 2.82
2017-12-31 $0.74B $0.28B 2.66
2017-09-30 $0.78B $0.30B 2.59
2017-06-30 $0.72B $0.29B 2.48
2017-03-31 $0.65B $0.26B 2.54
2016-12-31 $0.64B $0.24B 2.66
2016-09-30 $0.66B $0.24B 2.78
2016-06-30 $0.66B $0.24B 2.75
2016-03-31 $0.63B $0.24B 2.62
2015-12-31 $0.67B $0.31B 2.14
2015-09-30 $0.68B $0.30B 2.27
2015-06-30 $0.68B $0.31B 2.17
2015-03-31 $0.63B $0.30B 2.11
2014-12-31 $0.66B $0.25B 2.61
2014-09-30 $0.68B $0.24B 2.80
2014-06-30 $0.69B $0.22B 3.10
2014-03-31 $0.69B $0.23B 3.02
2013-12-31 $0.65B $0.24B 2.75
2013-09-30 $0.64B $0.25B 2.61
2013-06-30 $0.61B $0.22B 2.80
2013-03-31 $0.59B $0.21B 2.83
2012-12-31 $0.56B $0.26B 2.13
2012-09-30 $0.56B $0.28B 2.02
2012-06-30 $0.52B $0.32B 1.62
2012-03-31 $0.50B $0.30B 1.66
2011-12-31 $0.47B $0.24B 1.94
2011-09-30 $0.50B $0.23B 2.20
2011-06-30 $0.51B $0.19B 2.65
2011-03-31 $0.48B $0.18B 2.63
2010-12-31 $0.44B $0.17B 2.57
2010-09-30 $0.44B $0.16B 2.79
2010-06-30 $0.40B $0.16B 2.55
2010-03-31 $0.41B $0.18B 2.20
2009-12-31 $0.40B $0.17B 2.32
2009-09-30 $0.40B $0.16B 2.45
2009-06-30 $0.40B $0.16B 2.45
2009-03-31 $0.36B $0.14B 2.57
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.683B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.526B 20.06
Becton Dickinson (BDX) United States $64.714B 17.01
Cardinal Health (CAH) United States $28.315B 15.35
Labcorp (LH) United States $18.984B 15.74
Cooper (COO) United States $18.348B 24.85
Align Technology (ALGN) United States $15.944B 30.51
Henry Schein (HSIC) United States $8.597B 16.38
Merit Medical Systems (MMSI) United States $5.611B 28.65
DENTSPLY SIRONA (XRAY) United States $3.671B 9.98
Patterson (PDCO) United States $2.730B 14.58
CONMED (CNMD) United States $2.162B 18.04
STAAR Surgical (STAA) United States $1.231B 45.42
Lifevantage (LFVN) United States $0.222B 29.55
Pro-Dex (PDEX) United States $0.151B 30.10